Cresset Asset Management, LLC Vanda Pharmaceuticals Inc. Transaction History

Cresset Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $110,860 - $169,256	-10,227 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$15.69 - $21.14 $160,461 - $216,198	10,227 New	10,227 $161,000
Q2 2019 Aug 12, 2019	SELL	$13.37 - $18.85 $802 - $1,131	-60 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$17.59 - $31.05 $844 - $1,490	-48 Reduced 44.44%	60 $1,000
Q4 2018 May 21, 2019	BUY	$18.97 - $31.47 $2,048 - $3,398	108 New	108 $3,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $278M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Cresset Asset Management, LLC with notifications on news.